K23 HL148548/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	1
2021	2
2022	3
2023	4
2024	3

1

Global perspectives on cellular therapy for children with sickle cell disease.

John TD, Namazzi R, Chirande L, Tubman VN. John TD, et al. Curr Opin Hematol. 2022 Nov 1;29(6):275-280. doi: 10.1097/MOH.0000000000000738. Epub 2022 Sep 21. Curr Opin Hematol. 2022. PMID: 36206076 Free PMC article. Review.

2

Unraveling the mystery of the spleen.

Tubman VN. Tubman VN. Am J Hematol. 2024 Feb;99(2):150-151. doi: 10.1002/ajh.27200. Epub 2024 Jan 8. Am J Hematol. 2024. PMID: 38189108 No abstract available.

3

Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries.

Archer NM, Inusa B, Makani J, Nkya S, Tshilolo L, Tubman VN, McGann PT, Ambrose EE, Henrich N, Spector J, Ohene-Frempong K. Archer NM, et al. BMJ Open. 2022 Mar 9;12(3):e057623. doi: 10.1136/bmjopen-2021-057623. BMJ Open. 2022. PMID: 35264367 Free PMC article.

4

Indications for transfusion in the management of sickle cell disease.

Han H, Hensch L, Tubman VN. Han H, et al. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):696-703. doi: 10.1182/hematology.2021000307. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889416 Free PMC article. Review.

5

Unique Hemoglobinopathy Pattern Following Treatment with Voxelotor.

Poventud-Fuentes I, Portillo TP, Olayinka L, Marcogliese AN, Tubman VN, Devaraj S. Poventud-Fuentes I, et al. Ann Clin Lab Sci. 2023 Jul;53(4):647-652. Ann Clin Lab Sci. 2023. PMID: 37625829

6

Allele-Specific Recombinase Polymerase Amplification to Detect Sickle Cell Disease in Low-Resource Settings.

Natoli ME, Chang MM, Kundrod KA, Coole JB, Airewele GE, Tubman VN, Richards-Kortum RR. Natoli ME, et al. Anal Chem. 2021 Mar 23;93(11):4832-4840. doi: 10.1021/acs.analchem.0c04191. Epub 2021 Mar 10. Anal Chem. 2021. PMID: 33689292 Free PMC article.

7

Ketamine for Pain in Sickle Cell Disease Reduces Opioid Usage.

Onyebuchi CO, Chumpitazi CE, Placencia JL, Jackson AN, Jones JL, Torres L, Tubman VN. Onyebuchi CO, et al. J Pain Symptom Manage. 2024 Mar;67(3):e169-e175. doi: 10.1016/j.jpainsymman.2023.11.012. Epub 2023 Nov 23. J Pain Symptom Manage. 2024. PMID: 38000561

8

Regional anesthesia for sickle cell disease vaso-occlusive crisis: A single-center case series.

Karsenty C, Tubman VN, Liu CJ, Fasipe T, Wyatt KEK. Karsenty C, et al. Pediatr Blood Cancer. 2022 Jun;69(6):e29695. doi: 10.1002/pbc.29695. Epub 2022 Apr 4. Pediatr Blood Cancer. 2022. PMID: 35373913 Free PMC article.

9

Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs.

Coria AL, Taylor CM, Tubman VN. Coria AL, et al. Am J Trop Med Hyg. 2020 Apr;102(4):902-904. doi: 10.4269/ajtmh.19-0541. Am J Trop Med Hyg. 2020. PMID: 32043441 Free PMC article.

10

Determinants of retention in care of newborns diagnosed with sickle cell disease in Liberia: Results from a mixed-methods study of caregivers.

Udhayashankar K, Franklin PD, Nuta CJ, Cherue AK, Haq H, Thompson D, Tubman VN. Udhayashankar K, et al. PLOS Glob Public Health. 2023 Apr 4;3(4):e0001705. doi: 10.1371/journal.pgph.0001705. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37014836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year